NAD+ Research Guide: is NAD+ a peptide?
NAD+ (nicotinamide adenine dinucleotide) is often sold alongside research peptides — many researchers search for "NAD+ peptide" — but it is not a peptide. It is a dinucleotide coenzyme found in every living cell, central to energy metabolism and used by enzymes such as sirtuins and PARPs. Animal studies report that NAD+ levels fall with age, which is why NAD+ research is a major focus of aging science. Supplied here as ≥99% purity lyophilised powder for laboratory research use only.
Specifications
| Compound class | Dinucleotide coenzyme (not a peptide) |
|---|---|
| CAS number | 53-84-9 |
| Molecular weight | 663.43 g/mol |
| Purity | ≥99% (HPLC) |
| Form | Lyophilised powder |
Why people search "NAD+ peptide"
NAD+ is stocked by peptide suppliers because it is handled the same way — supplied as a lyophilised powder and reconstituted in the lab. Chemically it is two nucleotides joined by a phosphate bridge, with no amino acids at all, so calling it a peptide is a category error rather than a naming variant.
The practical consequence is that peptide-specific reasoning does not transfer: there is no receptor binding sequence, no protease susceptibility in the peptide sense, and purity assays report on a small molecule rather than a synthesised chain.
What NAD+ does in cells
NAD+ carries electrons in the reactions that turn nutrients into cellular energy, cycling between its oxidised (NAD+) and reduced (NADH) forms in glycolysis, the TCA cycle and oxidative phosphorylation. In that role it is recycled, not consumed.
It is also consumed as a substrate by sirtuins, PARP enzymes and CD38, which link it to DNA repair, deacetylation signalling and cellular stress responses (Verdin, 2015). Because these enzymes destroy the molecule rather than recycle it, cellular NAD+ depends on continuous resynthesis.
Synthesis and salvage pathways
Cells make NAD+ de novo from tryptophan, and — far more heavily — recycle it through the salvage pathway from nicotinamide via NAMPT, or from precursors such as nicotinamide riboside and nicotinamide mononucleotide (Covarrubias et al., 2021).
Which pathway a model system relies on matters experimentally: NAMPT inhibition, precursor availability and tissue type all change how quickly a pool is replenished.
- De novo: from tryptophan, quantitatively minor in most tissues.
- Salvage: from nicotinamide via NAMPT, the dominant route.
- Precursor routes: nicotinamide riboside and NMN feed into the same pool.
NAD+ and ageing research
A 2018 review in Cell Metabolism summarised in-vivo evidence that raising NAD+ levels — mostly through precursors — affects metabolic and age-related measures in animal models (Rajman et al., 2018).
One proposed explanation for the age-related decline is increased consumption rather than reduced synthesis: Camacho-Pereira et al. (2016) reported that the NAD-consuming enzyme CD38 rises with age in mice and drives NAD+ decline through an SIRT3-dependent mechanism.
What has not been established
Most of the interventional evidence involves precursors in animal models, not NAD+ itself. Human data are smaller and shorter, and the reported outcomes are laboratory measures rather than long-term clinical endpoints.
Whether raising NAD+ in a model system produces the downstream effect a study is looking for is exactly the open question the field is testing. It should not be assumed in a study design.
Handling in the lab
Keep lyophilised NAD+ cold, dry and protected from light. NAD+ in solution is sensitive to heat and to alkaline pH, so prepare solutions fresh where possible, keep them refrigerated, and avoid repeated freeze-thaw cycles. Record lot and preparation date with each experiment.
Frequently asked questions
Is NAD+ a peptide?
No. NAD+ is a dinucleotide coenzyme. It is sold by peptide suppliers because it is supplied and handled in the same lyophilised format.
What does NAD+ stand for?
Nicotinamide adenine dinucleotide — two nucleotides joined by a phosphate bridge, in its oxidised form.
What is the difference between NAD+ and NADH?
They are the oxidised and reduced forms of the same coenzyme. NAD+ accepts electrons to become NADH, and the ratio between them reflects a cell's metabolic state.
What enzymes consume NAD+?
Sirtuins, PARPs and CD38 use NAD+ as a substrate and break it down, unlike the redox reactions that recycle it.
How do cells replenish NAD+?
Mainly through the salvage pathway from nicotinamide via NAMPT, with smaller contributions from tryptophan de novo synthesis and from precursors such as NR and NMN.
Why is NAD+ studied in aging research?
Animal studies report that NAD+ levels decline with age, and NAD+ is required by sirtuins and PARPs involved in DNA repair and stress responses.
Why does NAD+ decline with age?
One reported mechanism is increased consumption: CD38 activity rises with age in mice and drives NAD+ decline via an SIRT3-dependent mechanism (Camacho-Pereira et al., 2016).
Is NAD+ the same as NMN?
No. NMN is a precursor that cells convert into NAD+; they are different molecules. See the NAD+ vs NMN comparison for details.
Has NAD+ itself been tested in humans?
Most interventional human data involve precursors rather than NAD+ itself, and those studies are small and short. Long-term clinical outcomes have not been established.
How stable is NAD+ in solution?
It is sensitive to heat and alkaline pH. Prepare solutions fresh where possible, refrigerate them, and avoid repeated freeze-thaw cycles.
How should NAD+ be stored?
Keep lyophilised NAD+ cold, dry and protected from light; refrigerate reconstituted solutions.
What NAD+ sizes are available?
PeptidesDirect supplies NAD+ in 100mg and 750mg vials for laboratory research only. See our research peptides guide research peptides guide for how to compare suppliers and read test documents.
Product pages: NAD+ 100mg / 750mg
Is this product for human use?
No. PeptidesDirect sells this compound for laboratory research only. It is not a drug, food or cosmetic and is not for human or veterinary use. This page summarises published research and is not dosing or medical guidance.
Shop the compounds covered in these FAQs: NAD+ 100mg / 750mg
References
- Verdin E. NAD+ in aging, metabolism, and neurodegeneration. Science. 2015. PubMed 26785480
- Rajman L, et al. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab. 2018. PubMed 29514064
- Covarrubias AJ, et al. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021. PubMed 33353981
- Camacho-Pereira J, et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab. 2016. PubMed 27304511
Research compounds
Related guides
- NAD+ vs NMN compared
- SS-31 research guide
- Epithalon vs MOTS-c
- Research peptides guide
- Reconstitution guide
- Storage guide
Research Use Only. Not for human or veterinary use. Not dosing or medical guidance.
